{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T14:47:15Z","timestamp":1745765235536,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AFRICA RESEARCH EXCELLENCE FUND","award":["AREF-318-WOTO-F-C0872"],"award-info":[{"award-number":["AREF-318-WOTO-F-C0872"]}]},{"DOI":"10.13039\/100012947","name":"Institut de Recherche pour le D\u00e9veloppement","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012947","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pasteur Institute of Dakar"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Thanks to the scale up of malaria control interventions, the malaria burden in Senegal has decreased substantially to the point that the National Malaria Control Programme plans to achieve malaria elimination by 2030. To guide such efforts, measuring and monitoring parasite population evolution and anti-malarial drugs resistance is extremely important. Information on the prevalence of parasite mutations related to drug resistance can provide a first signal of emergence, introduction and selection that can help with refining drug interventions. The aim of this study was to analyse the prevalence of anti-malarial drug resistance-associated markers before and after the implementation of artemisinin-based combination therapy (ACT) from 2005 to 2014 in Dielmo, a model site for malaria intervention studies in Senegal.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Samples from both malaria patients and <jats:italic>Plasmodium falciparum<\/jats:italic> asymptomatic carriers were analysed with high resolution melting (HRM) technique to genotype <jats:italic>P. falciparum<\/jats:italic> chloroquine resistance transporter (<jats:italic>Pfcrt<\/jats:italic>)\u00a0gene haplotypes and multidrug-resistant protein 1 (<jats:italic>Pfmdr1<\/jats:italic>) gene at codons N86 and Y184.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 539 samples analysed, 474, 486, and 511 were successfully genotyped for <jats:italic>Pfmdr1<\/jats:italic> N86, Y184, and <jats:italic>Pfcrt<\/jats:italic>, respectively. The prevalence of drug resistance markers was high, particularly during the malaria upsurges. Following the scale-up in bed net distribution, only the mutant (86F-like) variant of <jats:italic>Pfmdr1<\/jats:italic> 86 was present while during the malaria upsurges the predominance of two types 86Y-86N (43%) and 86F-like (56%) were observed. Most infections (87%) carried the wild type Y-allele at <jats:italic>Pfmdr1<\/jats:italic>\u00a0184 during the period of nets scale-up while during the malaria upsurges only 16% of infections had wild type and 79% of infections had mixed (mutant\/wild) type. The frequency of the mixed genotypes SVMNT-like_CVMNK and SVMNT-like_CVIET within <jats:italic>Pfcrt<\/jats:italic> gene was particularly low during bednet scale up. Their frequency increased significantly (P\u2009&lt;\u20090.001) during the malaria upsurges.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This data demonstrated the effect of multiple interventions on the dynamics of drug resistance-associated mutations in the main malaria parasite <jats:italic>P. falciparum<\/jats:italic> in an endemic village in Senegal. Monitoring drug resistance markers should be conducted periodically to detect threats of emergence or resurgence that could compromise the efficacy of anti-malarial drugs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-023-04694-0","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T09:01:44Z","timestamp":1693904504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in Dielmo village, Senegal, West Africa"],"prefix":"10.1186","volume":"22","author":[{"given":"Am\u00e9l\u00e9 Nyedzie","family":"Wotodjo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Aigbiremo","family":"Oboh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souleymane","family":"Doucoure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafissatou","family":"Diagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatoumata","family":"Di\u00e8ne-Sarr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makhtar","family":"Niang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Trape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheikh","family":"Sokhna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Amambua-Ngwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"4694_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","volume":"77","author":"F Nosten","year":"2007","unstructured":"Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007;77:181\u201392.","journal-title":"Am J Trop Med Hyg"},{"key":"4694_CR2","first-page":"40","volume":"50","author":"PL Olliaro","year":"2004","unstructured":"Olliaro PL, Taylor WR. Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: a review. J Postgrad Med. 2004;50:40\u20134.","journal-title":"J Postgrad Med"},{"key":"4694_CR3","volume-title":"World malaria report","author":"WHO","year":"2015","unstructured":"WHO. World malaria report. Geneva: World Health Organization; 2015."},{"key":"4694_CR4","volume-title":"Senegal: Directives nationales de prevention et de prise en charge du paludisme","author":"PNLP","year":"2013","unstructured":"PNLP. Senegal: Directives nationales de prevention et de prise en charge du paludisme. PNLP: Dakar; 2013."},{"key":"4694_CR5","volume-title":"S\u00e9n\u00e9gal: Rapport d'activit\u00e9","author":"PNLP","year":"2010","unstructured":"PNLP. S\u00e9n\u00e9gal: Rapport d\u2019activit\u00e9. Dakar: PNLP; 2010."},{"key":"4694_CR6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/infdis\/jir805","volume":"205","author":"JF Trape","year":"2012","unstructured":"Trape JF, Sauvage C, Ndiaye O, Douillot L, Marra A, Diallo A, et al. New malaria-control policies and child mortality in senegal: reaching millennium development goal 4. J Infect Dis. 2012;205:672\u20139.","journal-title":"J Infect Dis"},{"key":"4694_CR7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0764-4469(98)80009-7","volume":"321","author":"JF Trape","year":"1998","unstructured":"Trape JF, Pison G, Preziosi MP, Enel C, Desgrees du Lou A, Delaunay V, et al. Impact of chloroquine resistance on malaria mortality. C R Acad Sci. 1998;321:689\u201397.","journal-title":"C R Acad Sci."},{"key":"4694_CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"4694_CR9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"4694_CR10","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana JM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26:1602\u20138.","journal-title":"Nat Med"},{"key":"4694_CR11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana SI, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"4694_CR12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimd\u00e9","year":"2001","unstructured":"Djimd\u00e9 A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourt\u00e9 Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257\u201363.","journal-title":"N Engl J Med"},{"key":"4694_CR13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12936-021-03942-5","volume":"20","author":"C Nsanzabana","year":"2021","unstructured":"Nsanzabana C. Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa. Malar J. 2021;20:401.","journal-title":"Malar J"},{"key":"4694_CR14","doi-asserted-by":"crossref","first-page":"e64299","DOI":"10.1371\/journal.pone.0064299","volume":"8","author":"FL Eyase","year":"2013","unstructured":"Eyase FL, Akala HM, Ingasia L, Cheruiyot A, Omondi A, Okudo C, et al. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008\u20132011. PLoS ONE. 2013;8:e64299.","journal-title":"PLoS ONE"},{"key":"4694_CR15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-3156.2007.01995.x","volume":"13","author":"H Tinto","year":"2008","unstructured":"Tinto H, Guekoun L, Zongo I, Guiguemd\u00e9 RT, D\u2019Alessandro U, Ou\u00e9draogo JB. Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso. Trop Med Int Health. 2008;13:238\u201340.","journal-title":"Trop Med Int Health"},{"key":"4694_CR16","doi-asserted-by":"crossref","first-page":"e13281","DOI":"10.1371\/journal.pone.0013281","volume":"5","author":"V Andriantsoanirina","year":"2010","unstructured":"Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Tichit M, Jahevitra M, Rabearimanana S, et al. Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar. PLoS ONE. 2010;5:e13281.","journal-title":"PLoS ONE"},{"key":"4694_CR17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1074045","volume":"298","author":"AB Sidhu","year":"2002","unstructured":"Sidhu AB, Verdier-Pinard D, Fidock DA. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science. 2002;298:210\u20133.","journal-title":"Science"},{"key":"4694_CR18","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1128\/AAC.00358-10","volume":"54","author":"K Beshir","year":"2010","unstructured":"Beshir K, Sutherland CJ, Merinopoulos I, Durrani N, Leslie T, Rowland M, et al. Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76. Antimicrob Agents Chemother. 2010;54:3714\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"4694_CR19","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00436-012-2994-7","volume":"111","author":"O Ly","year":"2012","unstructured":"Ly O, Gueye PE, Deme AB, Dieng T, Badiane AS, Ahouidi AD, et al. Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine. Senegal Parasitol Res. 2012;111:1541\u20136.","journal-title":"Senegal Parasitol Res"},{"key":"4694_CR20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1475-2875-12-441","volume":"12","author":"D Van Tyne","year":"2013","unstructured":"Van Tyne D, Dieye B, Valim C, Daniels RF, S\u00e8ne PD, Lukens AK, et al. Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal. Malar J. 2013;12:441.","journal-title":"Malar J"},{"key":"4694_CR21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"4694_CR22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/1475-2875-13-472","volume":"13","author":"M Torrentino-Madamet","year":"2014","unstructured":"Torrentino-Madamet M, Fall B, Benoit N, Camara C, Amalvict R, Fall M, et al. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012\u20132013. Malar J. 2014;13:472.","journal-title":"Malar J"},{"key":"4694_CR23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1473-3099(14)70712-1","volume":"14","author":"JF Trape","year":"2014","unstructured":"Trape JF, Tall A, Sokhna C, Ly AB, Diagne N, Ndiath O, et al. The rise and fall of malaria in a west African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study. Lancet Infect Dis. 2014;14:476\u201388.","journal-title":"Lancet Infect Dis"},{"key":"4694_CR24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1473-3099(11)70194-3","volume":"11","author":"JF Trape","year":"2011","unstructured":"Trape JF, Tall A, Diagne N, Ndiath O, Ly AB, Faye J, et al. Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis. 2011;11:925\u201332.","journal-title":"Lancet Infect Dis"},{"key":"4694_CR25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4269\/ajtmh.14-0485","volume":"92","author":"AN Wotodjo","year":"2015","unstructured":"Wotodjo AN, Diagne N, Gaudart J, Richard V, Raoult D, Sokhna C. Malaria risk factors in Dielmo, a Senegalese malaria-endemic village, between October and November of 2013: a case-control study. Am J Trop Med Hyg. 2015;92:565\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"4694_CR26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13071-015-0871-9","volume":"8","author":"AN Wotodjo","year":"2015","unstructured":"Wotodjo AN, Richard V, Boyer S, Doucoure S, Diagne N, Tour\u00e9-Bald\u00e9 A, et al. The implication of long-lasting insecticide-treated net use in the resurgence of malaria morbidity in a Senegal malaria endemic village in 2010\u20132011. Parasit Vectors. 2015;8:267.","journal-title":"Parasit Vectors"},{"key":"4694_CR27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4269\/ajtmh.1994.51.123","volume":"51","author":"JF Trape","year":"1994","unstructured":"Trape JF, Rogier C, Konate L, Diagne N, Bouganali H, Canque B, et al. The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg. 1994;51:123\u201337.","journal-title":"Am J Trop Med Hyg"},{"key":"4694_CR28","doi-asserted-by":"crossref","first-page":"e0179528","DOI":"10.1371\/journal.pone.0179528","volume":"12","author":"AN Wotodjo","year":"2017","unstructured":"Wotodjo AN, Doucoure S, Gaudart J, Diagne N, Diene Sarr F, Faye N, et al. Malaria in Dielmo, a Senegal village: is its elimination possible after seven years of implementation of long-lasting insecticide-treated nets? PLoS ONE. 2017;12:e0179528.","journal-title":"PLoS ONE"},{"key":"4694_CR29","doi-asserted-by":"crossref","first-page":"e1001788","DOI":"10.1371\/journal.pmed.1001788","volume":"12","author":"N Hofmann","year":"2015","unstructured":"Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015;12:e1001788.","journal-title":"PLoS Med"},{"key":"4694_CR30","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1128\/AAC.05737-11","volume":"56","author":"R Daniels","year":"2012","unstructured":"Daniels R, Ndiaye D, Wall M, McKinney J, S\u00e9ne PD, Sabeti PC, et al. Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum. Antimicrob Agents Chemother. 2012;56:2976\u201386.","journal-title":"Antimicrob Agents Chemother"},{"key":"4694_CR31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1475-2875-9-174","volume":"9","author":"BE Gama","year":"2010","unstructured":"Gama BE, Pereira-Carvalho GA, Lutucuta Kosi FJ, Almeida de Oliveira NK, Fortes F, Rosenthal PJ, et al. Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene. Malar J. 2010;9:174.","journal-title":"Malar J."},{"key":"4694_CR32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/jac\/dkt388","volume":"69","author":"HG Ngassa Mbenda","year":"2014","unstructured":"Ngassa Mbenda HG, Das A. Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum. J Antimicrob Chemother. 2014;69:400\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"4694_CR33","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1086\/504269","volume":"193","author":"M Alifrangis","year":"2006","unstructured":"Alifrangis M, Dalgaard MB, Lusingu JP, Vestergaard LS, Staalsoe T, Jensen AT, et al. Occurrence of the Southeast Asian\/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J Infect Dis. 2006;193:1738\u201341.","journal-title":"J Infect Dis"},{"key":"4694_CR34","volume-title":"Focus on Senegal-progress and impact series","author":"RBM","year":"2010","unstructured":"RBM. Focus on Senegal-progress and impact series. Geneva: World Health Organization; 2010."},{"key":"4694_CR35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijpddr.2015.05.005","volume":"5","author":"AO Achieng","year":"2015","unstructured":"Achieng AO, Muiruri P, Ingasia LA, Opot BH, Juma DW, Yeda R, et al. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya. Int J Parasitol Drugs Drug Resist. 2015;5:92\u20139.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"4694_CR36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-3156.2007.01843.x","volume":"12","author":"C Sisowath","year":"2007","unstructured":"Sisowath C, Ferreira PE, Bustamante LY, Dahlstr\u00f6m S, M\u00e5rtensson A, Bj\u00f6rkman A, et al. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop Med Int Health. 2007;12:736\u201342.","journal-title":"Trop Med Int Health"},{"key":"4694_CR37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40249-017-0350-y","volume":"6","author":"TO Apinjoh","year":"2017","unstructured":"Apinjoh TO, Mugri RN, Miotto O, Chi HF, Tata RB, Anchang-Kimbi JK, et al. Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of mount Cameroon: cross-sectional study. Infect Dis Poverty. 2017;6:136.","journal-title":"Infect Dis Poverty"},{"key":"4694_CR38","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/infdis\/jir486","volume":"204","author":"FN Baliraine","year":"2011","unstructured":"Baliraine FN, Rosenthal PJ. Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda. J Infect Dis. 2011;204:1120\u20134.","journal-title":"J Infect Dis"},{"key":"4694_CR39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.meegid.2005.09.001","volume":"6","author":"G Holmgren","year":"2006","unstructured":"Holmgren G, Gil JP, Ferreira PM, Veiga MI, Obonyo CO, Bj\u00f6rkman A. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect Genet Evol. 2006;6:309\u201314.","journal-title":"Infect Genet Evol"},{"key":"4694_CR40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.meegid.2007.03.005","volume":"7","author":"G Holmgren","year":"2007","unstructured":"Holmgren G, Hamrin J, Sv\u00e4rd J, M\u00e5rtensson A, Gil JP, Bj\u00f6rkman A. Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. Infect Genet Evol. 2007;7:562\u20139.","journal-title":"Infect Genet Evol"},{"key":"4694_CR41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12936-016-1490-4","volume":"15","author":"A Mbaye","year":"2016","unstructured":"Mbaye A, Dieye B, Ndiaye YD, Bei AK, Muna A, Deme AB, et al. Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal. Malar J. 2016;15:433.","journal-title":"Malar J"},{"key":"4694_CR42","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa062032","volume":"355","author":"MK Laufer","year":"2006","unstructured":"Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med. 2006;355:1959\u201366.","journal-title":"N Engl J Med"},{"key":"4694_CR43","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1371\/journal.pone.0000139","volume":"2","author":"N Noranate","year":"2007","unstructured":"Noranate N, Durand R, Tall A, Marrama L, Spiegel A, Sokhna C, et al. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS ONE. 2007;2:e139.","journal-title":"PLoS ONE"},{"key":"4694_CR44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4269\/ajtmh.2010.09-0470","volume":"82","author":"D Ndiaye","year":"2010","unstructured":"Ndiaye D, Patel V, Demas A, LeRoux M, Ndir O, Mboup S, et al. A non-radioactive DAPI-based high-throughput in vitro assay to assess Plasmodium falciparum responsiveness to antimalarials\u2013increased sensitivity of P. falciparum to chloroquine in Senegal. Am J Trop Med Hyg. 2010;82:228\u201330.","journal-title":"Am J Trop Med Hyg."},{"key":"4694_CR45","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4269\/ajtmh.2012.11-0709","volume":"87","author":"M Ndiaye","year":"2012","unstructured":"Ndiaye M, Faye B, Tine R, Ndiaye JL, Lo A, Abiola A, et al. Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal. Am J Trop Med Hyg. 2012;87:640\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"4694_CR46","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/1475-2875-9-374","volume":"9","author":"JM Sa","year":"2010","unstructured":"Sa JM, Twu O. Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type. Malar J. 2010;9:374.","journal-title":"Malar J"},{"key":"4694_CR47","doi-asserted-by":"crossref","first-page":"18883","DOI":"10.1073\/pnas.0911317106","volume":"106","author":"JM S\u00e1","year":"2009","unstructured":"S\u00e1 JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, et al. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci USA. 2009;106:18883\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4694_CR48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1475-2875-9-68","volume":"9","author":"SV Dlamini","year":"2010","unstructured":"Dlamini SV, Beshir K, Sutherland CJ. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates. Malar J. 2010;9:68.","journal-title":"Malar J"},{"key":"4694_CR49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4269\/ajtmh.2007.76.641","volume":"76","author":"AP Alker","year":"2007","unstructured":"Alker AP, Lim P, Sem R, Shah NK, Yi P, Bouth DM, et al. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg. 2007;76:641\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"4694_CR50","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438\u201347.","journal-title":"Lancet"},{"key":"4694_CR51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1475-2875-12-107","volume":"12","author":"B Fall","year":"2013","unstructured":"Fall B, Pascual A, Sarr FD, Wurtz N, Richard V, Baret E, et al. Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study. Malar J. 2013;12:107.","journal-title":"Malar J"},{"key":"4694_CR52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1475-2875-11-197","volume":"11","author":"N Wurtz","year":"2012","unstructured":"Wurtz N, Fall B, Pascual A, Diawara S, Sow K, Baret E, et al. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar. Senegal Malar J. 2012;11:197.","journal-title":"Senegal Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-023-04694-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04694-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T22:18:08Z","timestamp":1700259488000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-023-04694-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4694"],"URL":"https:\/\/doi.org\/10.1186\/s12936-023-04694-0","relation":{},"ISSN":["1475-2875"],"issn-type":[{"type":"electronic","value":"1475-2875"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"18 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ministry of Health of Senegal, the assembled village population and the National Ethics Committee of Senegal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript and agree to its submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}